Comparison of azasetron and ondansetron for preventing postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery

Yonsei Medical Journal

Volumn 51, Issue 1, 2010, Pages 88-92

  Yun, Mi Ja ^a   Kim, Yoon Hee ^b   Kim, A Rm ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

Author keywords

Azasetron; Gynecologic surgical procedures; Ondansetron; Postoperative nausea and vomiting; Prophylaxis

Indexed keywords

AZASETRON; METOCLOPRAMIDE; NALBUPHINE; ONDANSETRON; SEROTON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENERAL ANESTHESIA; GYNECOLOGIC SURGERY; HEADACHE; HUMAN; HYSTERECTOMY; INCIDENCE; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MYALGIA; PAIN ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; POSTOPERATIVE VOMITING; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

ADULT; AGED; BICYCLO COMPOUNDS, HETEROCYCLIC; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; ONDANSETRON; OXAZINES; POSTOPERATIVE NAUSEA AND VOMITING; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 75749153713     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.1.88     Document Type: Article

References (28)

1. Gan TJ. Postoperative nausea and vomiting - can it be eliminated? JAMA 2002;287:1233-6.
2. Ismail S. Practice of use of antiemetic in patients for laparoscopic gynaecological surgery and its impact on the early (1st two hrs) postoperative period. J Pak Med Assoc 2008;58:203-5.
3. Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62-71.
4. White PF, Watcha MF. Postoperative nausea and vomiting: prophylaxis versus treatment. Anesth Analg 1999;89:1337-9.
5. Tsukagoshi S. [Pharmacokinetics of azasetron (Serotone), a selective 5-HT3 receptor antagonist.] Gan To Kagaku Ryoho 1999;26:1001-8.
6. Haga K, Inaba K, Shoji H, Morimoto Y, Fukuda T, Setoguchi M. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agentinduced emesis. Jpn J Pharmacol 1993;63:377-83.
7. Sakamori M, Takehara S, Setoguchi M. [High affinity binding of Y-25130 for serotonin 3 receptor.] Nippon Yakurigaku Zasshi 1992;100:137-42.
8. Hayakawa T, Sato M, Konaka M, Makino A, Hirohata T, Totsu S, et al. [Comparison of ramosetron and azasetron for prevention of acute and delayed cisplatin-induced emesis in lung cancer patients.] Gan To Kagaku Ryoho 2006;33:633-8.
9. Kimura E, Niimi S, Watanabe A, Tanaka T. [Clinical effect of two azasetron treatment methods against nausea and vomiting induced by anticancer drugs including CDDP.] Gan To Kagaku Ryoho 1997;24:855-9.
10. Bhatnagar S, Gupta D, Mishra S, Srikanti M, Singh M, Arora R. Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study. J Clin Anesth 2007;19:512-6.
11. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999;91:693-700.
12. Krobbuaban B, Pitakpol S, Diregpoke S. Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery. J Med Assoc Thai 2008;91:669-74.
13. Sandhu T, Tanvatcharaphan P, Cheunjongkolkul V. Ondansetron versus metoclopramide in prophylaxis of nausea and vomiting for laparoscopic cholecystectomy: a prospective double-blind randomized study. Asian J Surg 2008;31:50-4.
14. Oksuz H, Zencirci B, Ezberci M. Comparison of the effectiveness of metoclopramide, ondansetron, and granisetron on the prevention of nausea and vomiting after laparoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A 2007;17:803-8.
15. Diemunsch P, Gan TJ, Philip BK, Girao MJ, Eberhart L, Irwin MG, et al. Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, doubleblind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth 2007;99:202-11.
16. Lee Y, Wang PK, Lai HY, Yang YL, Chu CC, Wang JJ. Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting. Can J Anaesth 2007;54:349-54.
17. Gan TJ. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs 2005;19:225-38.
18. Kovac AL. Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists. J Clin Anesth 2006;18:304-18.
19. Habib AS, Gan TJ. Evidence-based management of postoperative nausea and vomiting: a review. Can J Anaesth 2004;51:326-41.
20. Tramér MR, Reynolds DJ, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997;87:1277-89.
21. Fukuda T, Setoguchi M, Inaba K, Shoji H, Tahara T. The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist. Eur J Pharmacol 1991;196:299-305.
22. Ozaki A, Sukamoto T. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist. Gen Pharmacol 1999;33:283-8.
23. Odani N, Haga K, Setoguchi M. [Effect of Y-25130 on gastric motility in anesthetized rats.] Nippon Yakurigaku Zasshi 1993;101:17-26.
24. Ho ST, Wang JJ, Liu HS, Hu OY, Tzeng JI, Liaw WJ. Comparison of PCA nalbuphine and morphine in Chinese gynecologic patients. Acta Anaesthesiol Sin 1998;36:65-70.
25. Walder B, Schafer M, Henzi I, Tramèr MR. Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review. Acta Anaesthesiol Scand 2001;45:795-804.
26. Wu O, Belo SE, Koutsoukos G. Additive anti-emetic efficacy of prophylactic ondansetron with droperidol in out-patient gynecological laparoscopy. Can J Anaesth 2000;47:529-36.
27. Goll V, Akça O, Greif R, Freitag H, Arkiliç CF, Scheck T, et al. Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesth Analg 2001;92:112-7.
28. Larijani GE, Gratz I, Afshar M, Minassian S. Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo. Anesth Analg 1991; 73:246-9.